Low-dose radiation therapy for Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This trial tests if very low doses of radiation to the brain can reduce inflammation and slow memory loss in people with Alzheimer's or similar dementias. It involves monthly clinic visits for a year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older.
- You have a diagnosis of Alzheimer's, frontotemporal dementia, Lewy body dementia, or another dementia with brain inflammation.
- Your memory and thinking skills are moderately to mildly impaired (MoCA score 10–25).
- You have a caregiver or family member who can come with you to most visits.
- You have never had radiation therapy to your brain before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a very low dose of radiation for a brain PET scan can still give clear images. If you are eligible, you will get a type of radioactive tracer that helps show amyloid plaques in the brain, often used in Alzheimer's research.
This study tests if a near-infrared light therapy device can help improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves daily treatment sessions with the device, and a study partner must be available to help with treatment.
This trial tests a treatment that sends gentle electrical pulses to a part of the brain involved in memory and thinking. It is for people with early-stage Alzheimer's who live at home and have a caregiver who can help.
This Phase 2 study tests whether targeting “neuroinflammation” (inflammation in the brain) can help in Alzheimer’s disease and related memory disorders. You may help researchers by doing several brain scans (including a special PET/CT scan) along with MRI and amyloid imaging to understand what’s happening in the brain.
This study tests an experimental drug called Foralumab, which aims to calm overactive immune cells in the brain linked to Alzheimer's. It may help slow memory loss in people with early-stage Alzheimer's.
This study tests if giving very low doses of radiation to the brain could boost the immune system and slow down early Alzheimer's disease. It aims to see if this treatment is safe and possibly helpful for people with early symptoms.
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.